REVENUES and profits for the final three months of last year at pharmaceutical company United Drug were ahead of the same period in 2011.
In an interim management statement the company, which is listed on the Irish stock exchange, attributed much of the growth to its international operations.
Business outside of Ireland contributed in excess of 70pc of group profits.
It said that based on current results, it expects earnings for the year to the end of September 2013 to be between 5pc and 8pc ahead of last year.
“The Group also expects to deliver another strong cash flow performance in the year, which coupled with modest debt levels relative to earnings and significant financing facilities available leaves the Group well positioned to support its future growth objectives both organically and through acquisition,” the statement said.